Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Internal medicine, Pulmonary hypertension, Cardiology, Idiopathic pulmonary fibrosis, and Risk stratification.
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry
Mono and Combination Therapies in Pulmonary Arterial Hypertension Patients with Comorbidities: A COMPERA Analysis
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry
Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT study
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis
Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study
Detect Acute Porphyrias in Emergency Departments (DePorED) – a pilot study
Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry
Pulmonary Hypertension in Patients With COPD
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT)
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Risk stratification in pulmonary arterial hypertension using Bayesian analysis
Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
Risk assessment in pulmonary arterial hypertension
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry